Target identification via Oncolines® profiling and ResidenceTimer™ Target identification via Oncolines® profiling and ResidenceTimer™ Target identification via Oncolines® profiling and ResidenceTimer™ Oncolines®2023-08-22T16:25:52+02:00
Case study – Gene expression profiling to understand and combat drug resistance Case study – Gene expression profiling to understand and combat drug resistance Case study – Gene expression profiling to understand and combat drug resistance janneke2023-05-29T15:56:23+02:00
Combination matrix to determine Bliss independence synergy scores Combination matrix to determine Bliss independence synergy scores Combination matrix to determine Bliss independence synergy scores Oncolines®2023-05-29T14:24:33+02:00
Case Study – 3D spheroid drug sensitivity Case Study – 3D spheroid drug sensitivity Case Study – 3D spheroid drug sensitivity yvonne2023-05-29T15:56:55+02:00
Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancer Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancer Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancer Oncolines®2023-05-29T15:58:13+02:00
Case study – Synergistic interaction of olaparib and cisplatin Case study – Synergistic interaction of olaparib and cisplatin Case study – Synergistic interaction of olaparib and cisplatin Oncolines®2023-05-29T15:59:34+02:00
Case study – TTK patient stratification marker Case study – TTK patient stratification marker Case study – TTK patient stratification marker Oncolines®2023-05-29T16:00:20+02:00
Case study – MEK inhibitor Case study – MEK inhibitor Case study – MEK inhibitor Oncolines®2023-05-29T16:01:07+02:00
Case study – Kadcyla® Case study – Kadcyla® Case study – Kadcyla® Oncolines®2023-05-29T16:01:43+02:00
